| Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ... Science 357 (6356), 1156-1160, 2017 | 1326 | 2017 |
| Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies CR Gurbatri, I Lia, R Vincent, C Coker, S Castro, PM Treuting, ... Science translational medicine 12 (530), eaax0876, 2020 | 319 | 2020 |
| Engineering bacteria as interactive cancer therapies CR Gurbatri, N Arpaia, T Danino Science 378 (6622), 858-864, 2022 | 95 | 2022 |
| Active matter S Tibbits MIT press, 2017 | 58 | 2017 |
| Probiotic-guided CAR-T cells for solid tumor targeting RL Vincent, CR Gurbatri, F Li, A Vardoshvili, C Coker, J Im, ER Ballister, ... Science 382 (6667), 211-218, 2023 | 26 | 2023 |
| Probiotic-guided CAR-T cells for universal solid tumor targeting RL Vincent, CR Gurbatri, A Redenti, C Coker, N Arpaia, T Danino bioRxiv, 2021 | 8 | 2021 |
| Colorectal cancer detection and treatment with engineered probiotics CR Gurbatri, G Radford, L Vrbanac, C Coker, J Im, SR Taylor, YU Jang, ... bioRxiv, 2023.04. 03.535370, 2023 | 3 | 2023 |
| Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia CR Gurbatri, GA Radford, L Vrbanac, J Im, EM Thomas, C Coker, ... Nature Communications 15 (1), 646, 2024 | 2 | 2024 |
| Engineered probiotics for local delivery of checkpoint blockade nanobodies C Gurbatri, I Lia, R Vincent, C Coker, S Castro, P Treuting, T Hinchliffe, ... Cancer Research 80 (16_Supplement), 6248-6248, 2020 | 1 | 2020 |
| Engineered probiotics direct the antigen specificity of CAR-T cells in situ RL Vincent, F Li, A Vardoshvili, C Gurbatri, N Arpaia, T Danino Cancer Research 84 (6_Supplement), 5237-5237, 2024 | | 2024 |
| Probiotic-Guided CAR-T Cells for Tumor Targeting T Danino, N Arpaia, R Vincent, T Savage, IM Jongwon, C Gurbatri US Patent App. 18/451,576, 2024 | | 2024 |
| Engineering Probiotic E. coli Nissle 1917 for Release of Therapeutic Nanobodies C Gurbatri, T Danino Cancer Immunotherapy: Methods and Protocols, 289-305, 2023 | | 2023 |
| Colon cancer screening and treatment with engineered probiotics CR Gurbatri, G Radford, J Im, C Coker, N Arpaia, SL Woods, DL Worthley, ... Cancer Research 83 (7_Supplement), 6525-6525, 2023 | | 2023 |
| Probiotic neoantigen delivery vectors for precision cancer immunotherapy A Redenti, J Im, B Redenti, F Li, M Rouanne, Z Sheng, W Sun, ... bioRxiv, 2023.09. 29.560228, 2023 | | 2023 |
| Engineered probiotics for the screening and treatment of colorectal cancer CR Gurbatri Columbia University, 2022 | | 2022 |
| Programmable bacteria for the treatment of cancer T Danino, N Arpaia, S Chowdhury, C Gurbatri US Patent App. 17/152,893, 2021 | | 2021 |
| Programmable bacteria for the treatment of cancer T DANINO, N ARPAIA, S CHOWDHURY, C GURBATRI | | 2020 |
| Programmable Bacteria: An Emerging Therapeutic C Gurbatri, T Harimoto, T Danino | | 2017 |
| Programmable Bacteria: An Emerging Therapeutic Candice Gurbatri, Tetsuhiro Harimoto, and T Danino Active Matter, 69, 2017 | | 2017 |
